Lauren Maselli
Internal Medicine · Hallandale Beach, FLNPI 1750773537
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 175 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by Novo Nordisk at 25.8% of the total. Reporting peaked in 2019 at $1,516 and has fallen 99.1% since, to $14 in 2025.
Across 175 payments — averaging $19.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$878
- AbbVie$656
- AstraZeneca$411
- Lilly USA, LLC$388
- Pfizer$293
- Boehringer Ingelheim$248
- plus $535 from 9 others
What the payments were for
- Food & beverage$3,403100%
- Education$50%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 37 | $878 |
| AbbVie(2 entities) | 27 | $656 |
| AstraZeneca | 23 | $411 |
| Lilly USA, LLC | 22 | $388 |
| Pfizer | 20 | $293 |
| Boehringer Ingelheim | 14 | $248 |
| Sanofi-aventis U.S. LLC | 12 | $195 |
| Amgen | 8 | $114 |
| Merck | 4 | $69 |
| GSK | 3 | $66 |
| Redhill Biopharma Inc. | 1 | $26 |
| Phadia US Inc. | 1 | $17 |
| Genentech USA, Inc. | 1 | $17 |
| Amarin Pharma, Inc. | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,408 in reported general payments places this provider in the 85th percentile of 8,530 internal medicine providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trazodone Hcl | 14 | $295 |
| Atorvastatin Calcium | 17 | $262 |
| Nifedipine ErNifedipine | 11 | $220 |
| Losartan Potassium | 13 | $141 |
| Amlodipine Besylate | 13 | $131 |
| Lisinopril | 11 | $81 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Hallandale Beach
- Haytham ElgammalMiami$2.2M
- Keith RubinFort Lauderdale$2M
- Michael SensionFort Lauderdale$1M
- Quang NguyenOcala$434K
- Luis Correa LunaSanford$412K
- Michael OleksykFort Myers$365K
- Andrew KuykendallTampa$322K
- Howard FederoffCoconut Grove$302K
- Bianka EperjesiovaGainesville$260K
- Julio ConradoFort Myers$247K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.